BM
ALXN

Bridger Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Bridger Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-422,254
Closed -$66M – 49
2020
Q4 		$66M Buy
422,254
+43,800
+12% +$5.63M 5.03% 5
2020
Q3 		$43.3M Buy
+378,454
New +$40.8M 3.46% 11
2019
Q1 		– Sell
-200,049
Closed -$19.5M – 36
2018
Q4 		$19.5M Buy
+200,049
New +$23.6M 1.62% 25
2018
Q2 		– Sell
-92,074
Closed -$10.3M – 41
2018
Q1 		$10.3M Buy
+92,074
New +$11M 0.62% 35
2017
Q4 		– Sell
-555,120
Closed -$77.9M – 39
2017
Q3 		$77.9M Buy
555,120
+349,114
+169% +$47.4M 4.84% 4
2017
Q2 		$25.1M Buy
+206,006
New +$24M 1.43% 30

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $7.94B AUM 55.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $14.1B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $4.65B AUM 56.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return